← The Wire
RLYBNasdaq
Rallybio Corp
Pharmaceutical Preparations · DE · CIK 1739410
Develops and commercializes life-transforming therapies for severe and rare diseases
red 8-K · 90d
$92M
Market cap
$16.06
Last close
+0.4%
1D
+0.8%
5D
31K
Volume
Price · last 39 sessions+13.7%
May 4L $14.00 · H $16.87Jun 29
92
Total filings
Jun 1, 2026
Last filing
12/31
Fiscal year end
425425Jun 1, 20268-KChange of Control · Executive ChangeJun 1, 202610-Q10-QMay 13, 2026SC 13D/ASC 13D/AMay 6, 20268-KAgreement TerminatedMay 4, 20268-KExecutive ChangeMar 31, 2026S-4S-4Mar 17, 202610-K10-KMar 16, 2026SC 13D/ASC 13D/AMar 3, 2026425425Mar 2, 20268-KChange of Control · Executive ChangeMar 2, 2026SC 13D/ASC 13D/AFeb 27, 20268-KBylaw Amendment · Shareholder VoteJan 29, 2026DEF 14ADEF 14AJan 2, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KDelisting NoticeAug 29, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KMaterial Agreement · Acquisition / DispositionJul 8, 20258-KExecutive ChangeJun 27, 20258-KShareholder VoteMay 16, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KCompany UpdateApr 8, 2025DEF 14ADEF 14AApr 7, 20258-KCompany UpdateMar 13, 2025424B5424B5Mar 13, 202510-K10-KMar 13, 20258-KResults of OperationsMar 13, 20258-KDelisting NoticeFeb 25, 202510-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KExecutive ChangeSep 17, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KExecutive ChangeJul 23, 20248-KShareholder VoteMay 21, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEF 14ADEF 14AApr 11, 20248-KMaterial Agreement · Equity IssuanceApr 10, 202410-K10-KMar 12, 20248-KResults of OperationsMar 12, 20248-KResults of Operations · Exit / Disposal CostsFeb 6, 20248-KReg FD DisclosureDec 20, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 9, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KExecutive ChangeJun 29, 20238-KShareholder VoteMay 22, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEF 14ADEF 14AApr 10, 202310-K10-KMar 6, 20238-KResults of Operations · Reg FD DisclosureMar 6, 20238-KExecutive ChangeJan 31, 20238-KCompany UpdateDec 1, 2022SC 13GSC 13GNov 17, 20228-KMaterial Agreement · Company UpdateNov 14, 2022424B5424B5Nov 14, 2022424B5424B5Nov 10, 202210-Q10-QNov 7, 20228-KResults of OperationsNov 7, 20228-KReg FD DisclosureSep 28, 2022424B5424B5Aug 15, 202210-Q10-QAug 8, 20228-KResults of OperationsAug 8, 20228-KExecutive Change · Reg FD DisclosureAug 2, 20228-KExecutive ChangeJun 2, 20228-KShareholder VoteMay 27, 202210-Q10-QMay 10, 20228-KMaterial Agreement · Results of OperationsMay 10, 2022DEF 14ADEF 14AApr 25, 20228-KExecutive Change · Reg FD DisclosureApr 4, 202210-K10-KMar 15, 20228-KResults of OperationsMar 15, 20228-KReg FD DisclosureMar 7, 2022SC 13GSC 13GFeb 11, 2022
Insider Activity
In the 90 days to Feb 23, 2026: 1 sold $4K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Lieber Jonathan IChief Financial Officer | Sell | 789 | $5.06 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance